Allerød, Denmark

Peter Bregnedal


Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 30(Granted Patents)


Location History:

  • Allerod, DK (1990)
  • Aller.o slashed.d, DK (1997 - 1998)
  • Allerød, DK (2001 - 2008)

Company Filing History:


Years Active: 1990-2008

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Peter Bregnedal: A Pioneer in Pharmaceutical Innovations

Introduction

Peter Bregnedal, an accomplished inventor residing in Allerød, Denmark, boasts an impressive portfolio of five patents. His innovative work primarily focuses on pharmaceutical compounds that aid in important neurological functions, showcasing his contribution to the field of medicine.

Latest Patents

Among his latest inventions is a patent for "Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors." This invention pertains to compounds that demonstrate dual efficacy in inhibiting both serotonin and norepinephrine uptake, which could have significant implications for treating various mental health conditions.

Another noteworthy patent is the "Method for the preparation of citalopram," which details a unique process for synthesizing the antidepressant medication citalopram. This process involves a sequence of reactions that ultimately produce a key compound beneficial for mental health treatment, again illustrating Peter's commitment to advancing pharmaceutical science.

Career Highlights

Peter Bregnedal is currently affiliated with H. Lundbeck A/S, a global pharmaceutical company specializing in brain disorders. His work there has allowed him to refine his inventive processes and contribute to essential medications that assist countless patients worldwide.

Collaborations

Throughout his career, Peter has collaborated with skilled professionals in the field, including colleagues such as Klaus Peter Bo and Hans Petersen. These partnerships have been instrumental in fostering a creative environment that prioritizes innovation and discovery in pharmaceuticals.

Conclusion

Peter Bregnedal's work exemplifies dedication to improving mental health through innovation. His esteemed patents reflect his expertise and commitment to finding effective solutions for neurological disorders. As he continues to explore new avenues in pharmaceutical science, his contributions are likely to make a lasting impact on the industry and society at large.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…